Vanda Pharmaceuticals VNDA reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:00 PM.
Here's what investors need to know about the announcement.
Vanda Pharmaceuticals their estimated earnings by 12.5%, reporting an EPS of $0.14 versus an estimate of $0.16, which surprised analysts.
Revenue was up $9,787,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03, which was followed by a 8.5% drop in the share price the next day.
Here's a look at Vanda Pharmaceuticals's past performance:
|Quarter||Q2 2021||Q1 2021||Q4 2020||Q3 2020|
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.